Project Grant HT94252510547
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$543K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01609, USA
Similar Awards
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $759,974 to Washington State University to develop a novel technique for introducing mutations in the native VlsE gene of Borrelia burgdorferi. The objective is to test several mechanistic concepts of VlsE-mediated immune evasion. This 3-year research project, starting on May 1, 2024 and ending on April 30, 2027, aims to advance the...
The Defense Health Agency awarded Duke University a $1,255,621 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop diagnostic and therapeutic agents targeting Borrelia burgdorferi, the causative agent of Lyme disease. The grant, with a performance period from September 15, 2024 to September 14, 2027, will enable Duke to conduct innovative biomedical research aimed at improving health outcomes for military service members and the broader public. As a...
This federal Project Grant award of $1,176,645.00, granted by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the development of a highly accurate proteomic diagnostic assay to identify active Borreliosis (Lyme disease) infection with point-of-need collection technology. The grant recipient, George Mason University, will conduct this research in collaboration with a subcontract to The Johns Hopkins University, which will provide...
The Department of Defense's Defense Health Agency awarded a $1,330,054 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of California, San Francisco (UCSF). The grant supports the "CLINICAL VALIDATION AND IMPLEMENTATION OF A HOST-PATHOGEN-BASED DIAGNOSTIC ASSAY FOR EARLY LYME DISEASE AND OTHER TICK-BORNE INFECTIONS" project, with a performance period from July 1, 2024 to June 30, 2027. As a leading academic medical...
The Department of the Army Medical Command awarded $754,214 to The Research Foundation for the State University of New York at Stony Brook University under the Military Medical Research and Development program (CFDA 12.420) from September 1, 2022 to August 31, 2025. The project aims to develop peripheral blood biomarkers to diagnose active Lyme disease and post-treatment Lyme disease syndrome. Stony Brook University will investigate medical solutions for Lyme disease diagnosis through innovative...
The Department of the Army Medical Command awarded a $449,402 Project Grant to Texas A&M University System Health Science Center through the Military Medical Research and Development program. The grant will fund research from September 2021 to August 2023 to investigate the role of the adenylate cyclase CyAB and the cyclic AMP signaling pathway at the Borrelia burgdorferi host-pathogen interface. The Military Medical Research and Development program aims to advance biomedical research that...
The University of Maryland, College Park was awarded a $1,292,721.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 30, 2025, supports the development of "Novel Small-Molecule Therapeutics Against Lyme Disease" over a project period ending on September 29, 2028. This research effort aims to transform healthcare for military service members, veterans, and the public...
The Defense Health Agency awarded The Johns Hopkins University a $818,750 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Immune System Disturbances After Borrelia Burgdorferi Infection". The project will take place over 3 years from August 1, 2023 to July 31, 2026. As a leading research university, Johns Hopkins has extensive experience providing biomedical research, public health initiatives, and scientific analysis to...
The U.S. Defense Health Agency awarded a $1,161,428 Project Grant to the University of California, Los Angeles (UCLA) under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 1, 2025, supports the development of a "Fully Automated, Multimodal, and Multiplexed Ferrobotic System for Point-of-Care Pathogenic and Serological Tick-Borne Disease Diagnosis." This advanced biomedical research project aims to transform healthcare for military...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $191,250 to Washington State University (WSU) to conduct research on the immune evasion mechanism of the Lyme disease spirochete, Borrelia burgdorferi. The award supports mechanistic studies on the role of genetic factors in the antigenic variation of the VlsE surface protein, a key mechanism for persistent...